SE410312B - Forfarande for framstellning av vissa angivna oximetrar - Google Patents

Forfarande for framstellning av vissa angivna oximetrar

Info

Publication number
SE410312B
SE410312B SE7603341A SE7603341A SE410312B SE 410312 B SE410312 B SE 410312B SE 7603341 A SE7603341 A SE 7603341A SE 7603341 A SE7603341 A SE 7603341A SE 410312 B SE410312 B SE 410312B
Authority
SE
Sweden
Prior art keywords
oximeters
procedure
manufacture
certain stated
stated
Prior art date
Application number
SE7603341A
Other languages
English (en)
Swedish (sv)
Other versions
SE7603341L (sv
Inventor
H B A Welle
V Claassen
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of SE7603341L publication Critical patent/SE7603341L/xx
Publication of SE410312B publication Critical patent/SE410312B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7603341A 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar SE410312B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (2)

Publication Number Publication Date
SE7603341L SE7603341L (sv) 1976-09-21
SE410312B true SE410312B (sv) 1979-10-08

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603341A SE410312B (sv) 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar

Country Status (27)

Country Link
US (1) US4085225A (enExample)
JP (1) JPS6026776B2 (enExample)
AR (2) AR211011A1 (enExample)
AT (1) AT340895B (enExample)
AU (1) AU505358B2 (enExample)
BE (1) BE839744A (enExample)
CA (1) CA1076142A (enExample)
CH (4) CH626057A5 (enExample)
DD (1) DD128332A5 (enExample)
DE (1) DE2610886A1 (enExample)
DK (1) DK144942C (enExample)
ES (1) ES446192A1 (enExample)
FI (1) FI61875C (enExample)
FR (1) FR2304336A1 (enExample)
GB (1) GB1535226A (enExample)
GR (1) GR60052B (enExample)
HU (1) HU171030B (enExample)
IE (1) IE43768B1 (enExample)
IL (1) IL49238A (enExample)
IT (1) IT1063064B (enExample)
MX (1) MX9203723A (enExample)
NL (1) NL7503310A (enExample)
PL (3) PL100052B1 (enExample)
SE (1) SE410312B (enExample)
SU (3) SU635867A3 (enExample)
YU (1) YU39345B (enExample)
ZA (1) ZA761434B (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
ATE192042T1 (de) * 1995-08-16 2000-05-15 Lilly Co Eli Potenzierung von serotonin-wirkstoffresponz
IN182588B (enExample) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (enExample) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
AU2001255654B2 (en) 2000-04-24 2005-09-22 Aryx Therapeutics Materials and methods for the treatment of depression
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
CN105712985A (zh) * 2001-10-12 2016-06-29 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
CN1849153A (zh) 2003-09-12 2006-10-18 辉瑞大药厂 含有α－2－δ配体和5－羟色胺/去甲肾上腺素重摄取抑制剂的组合物
DK1689721T3 (da) * 2003-11-26 2010-09-20 Pfizer Prod Inc Aminopyrazolderivater som GSK-3-ihibitorer
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2601709C (en) 2005-03-22 2017-02-14 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids
AR055054A1 (es) * 2005-04-22 2007-08-01 Wyeth Corp Cristales formados de clorhidrato de (((2r)-7-(2,6-diclorofenil)-5-fluoro-2,3- dihidro-1-benzofurano-2-il) metil ) amina
EP1871755A1 (en) 2005-04-22 2008-01-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
CN101203216A (zh) * 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
US7368477B2 (en) 2005-04-22 2008-05-06 Wyeth Benzofuranyl alkanamine derivatives and uses thereof
EP1904843A2 (en) 2005-07-08 2008-04-02 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
US8048874B2 (en) 2005-07-19 2011-11-01 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
RU2008135326A (ru) * 2006-03-24 2010-04-27 Вайет (Us) Терапевтические композиции для лечения депрессии
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
CA2662491A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
EP2288345B1 (en) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SMT201900392T1 (it) 2009-10-23 2019-09-09 Janssen Pharmaceutica Nv Ottaidropirrolo[3,4-c]pirroli disostituiti come modulatori del recettore di orexina
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
CA2804001C (en) 2010-07-01 2021-02-09 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
EP2685966A1 (en) 2011-03-17 2014-01-22 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
IN2013MU01290A (enExample) 2013-04-03 2015-04-10 Zcl Chemicals Ltd
JP6723930B2 (ja) 2014-02-07 2020-07-15 エムティーエー タモガトット クタトクソポルトク イロダジャ シグマ−１−受容体アゴニスト化合物の新規使用
CA2944211C (en) 2014-03-28 2022-10-04 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
SI3426251T1 (sl) 2016-03-10 2022-07-29 Janssen Pharmaceutica Nv Postopki za zdravljenje depresije z antagonisti receptorja oreksina-2
ES2926179T3 (es) 2016-11-24 2022-10-24 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Utilización de composiciones para la conservación de órganos/tejidos
KR102790657B1 (ko) 2017-09-15 2025-04-02 아제반 파마슈티칼스, 인코퍼레이티드 뇌 손상을 치료하기 위한 조성물 및 방법
JP7739256B2 (ja) 2019-07-19 2025-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
AR211011A1 (es) 1977-10-14
ATA195476A (de) 1977-05-15
DK115976A (da) 1976-09-21
ZA761434B (en) 1977-10-26
MX9203723A (es) 1992-07-01
YU39345B (en) 1984-10-31
DK144942C (da) 1982-12-06
FR2304336A1 (fr) 1976-10-15
SU645559A3 (ru) 1979-01-30
PL100052B1 (pl) 1978-08-31
AT340895B (de) 1978-01-10
FI61875C (fi) 1982-10-11
CH629761A5 (de) 1982-05-14
JPS51125345A (en) 1976-11-01
GR60052B (en) 1978-04-04
PL100614B1 (pl) 1978-10-31
DK144942B (da) 1982-07-12
IT1063064B (it) 1985-02-11
PL101951B1 (pl) 1979-02-28
AR211153A1 (es) 1977-10-31
GB1535226A (en) 1978-12-13
SU635867A3 (ru) 1978-11-30
NL7503310A (nl) 1976-09-22
YU71476A (en) 1982-10-31
SU620206A3 (ru) 1978-08-15
CH629184A5 (de) 1982-04-15
JPS6026776B2 (ja) 1985-06-25
HU171030B (hu) 1977-10-28
DE2610886A1 (de) 1976-10-07
DD128332A5 (de) 1977-11-09
CH629477A5 (de) 1982-04-30
CH626057A5 (enExample) 1981-10-30
IE43768L (en) 1976-09-20
FI760699A7 (enExample) 1976-09-21
BE839744A (fr) 1976-09-20
FI61875B (fi) 1982-06-30
IE43768B1 (en) 1981-05-20
FR2304336B1 (enExample) 1979-09-28
US4085225A (en) 1978-04-18
AU505358B2 (en) 1979-11-15
IL49238A0 (en) 1976-05-31
IL49238A (en) 1978-08-31
SE7603341L (sv) 1976-09-21
DE2610886C2 (enExample) 1987-09-24
AU1214776A (en) 1977-09-22
CA1076142A (en) 1980-04-22
ES446192A1 (es) 1977-10-01

Similar Documents

Publication Publication Date Title
SE410312B (sv) Forfarande for framstellning av vissa angivna oximetrar
AU510466B2 (en) Blood substitute based on haemoglobin
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
NL191332C (nl) Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
IT7921692A0 (it) Prodotto dotato di attivita&#39; sul cervello.
TR20394A (tr) 2,4-cift ikameli-5-tiazolkarboksilik asitler ve tuerevler
SE7410757L (enExample)
SE7905922L (sv) N-(diaminofosfinyl)-arylkarboxamider
FR2358160A1 (fr) Produit destine a declencher la parturition, a faciliter la fecondation et a augmenter la lactation chez la femme et chez les mammiferes, notamment le betail
AU570552B2 (en) 1,4-dihydropyridine-3-carboxylates and salts thereof
HK17880A (en) N-(1&#39;-allyl-2&#39;-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
SE8301997L (sv) Framstellning av 6,11-dihydro-11-oxodibens(b,e)-oxepin-2-ettiksyra
SE7509764L (sv) Forfarande for framstellning av omega-nor-cykloalkyl-13,14-dehydro-prostaglandiner
BG34607A3 (bg) Фунгицидно средство
USD243123S (en) Tibial template for knee joint reconstruction
USD245209S (en) Shoe
ATA199377A (de) Verfahren zur herstellung von 2,6-di-tert.butylphenol
USD245207S (en) Shoe
USD245210S (en) Shoe
ES8306467A1 (es) Procedimiento para la preparacion de alfa-hidroxiacidos.
SU640003A1 (ru) Стыковое соединение
SU566919A1 (ru) Термоактивный щит опалубки
MX3908E (es) Procedimiento para la purificacion de derivados de acido-4,4&#39;-bis-triazenilamino-estilben-2,2&#39;-disulfonico y las sales del mismo
SU523652A1 (ru) Культиватор дл ухода за лесными культурами
SU626778A1 (ru) Способ повышени активности комплемента крови морских свинок

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7603341

SPCG Supplementary protection certificate granted

Free format text: 7603341, EXPIRES: 20010317

NAL Patent in force

Ref document number: 7603341-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7603341-4

Format of ref document f/p: F